Glycomics Market
- Published Date: Aug-2021 |
- 180 Pages |
- Report ID: HE0258
Glycomics Market
Glycomics market is expected to grow from USD 1.06 billion in 2019 to USD 2.40 billion by 2026 at a CAGR of 14.62% from 2020 to 2026.
Glycomics is the complete study of glycoses, which incorporates pathologic, genetic, physiologic, and other aspects. Numerous techniques like mass spectrometry, high-performance liquid chromatography (HPLC), and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) are employed by professionals for glycomics application. The development of this market is majorly driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth within the proteomics market. The major factors that drive the market growth are the rise in demand for personalized medicine and commercialization of pharmaceutical & biotechnology research. Nevertheless, the lack of awareness among professionals about the importance of glycomics may impede the market growth. Additionally, the rise in aid from public and personal organizations, government bodies, and therefore the International Bank for Reconstruction and Development for glycomics and proteomics research is anticipated to present numerous opportunities for key players. The global market is segregated on the basis of Product as Enzymes, Other Enzymes, Instruments, Kits, Carbohydrates, and Reagents & Chemicals. Based on Application the global market is segmented in Drug Discovery & Development, Disease Diagnostics, and Other Applications. Based on End User, the global market is segmented in Academic Research Institutes, Pharmaceutical and Biotechnology Companies, and Clinical Laboratories.
The global market report provides geographical analysis covering regions, such as The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Merck KGaA, Thermo Fisher Scientific, Takara Bio, Inc., New England Biolabs, S-Bio (Subsidiary of Sumitomo Bakelite Co., Ltd.), Aspatria Glycomics S.L., Agilent Technologies, Bio-Techne, Shimadzu Corporation, Bruker Corporation, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Glycomics market has been segmented as below:
By Product
- Enzymes
- Other Enzymes
- Instruments
- Kits
- Carbohydrates
- Reagents & Chemicals
By Application
- Drug Discovery & Development
- Disease Diagnostics
- Other Applications
By End-User
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
Glycomics Market, By Company
- Merck KGaA
- Thermo Fisher Scientific
- Takara Bio, Inc.
- New England Biolabs
- S-Bio (Subsidiary of Sumitomo Bakelite Co., Ltd.)
- Asparia Glycomics S.L.
- Agilent Technologies
- Bio-Techne
- Shimadzu Corporation
- Bruker Corporation
- Waters Corporation
- AB Sciex Pte. Ltd. (Subsidiary of Danaher Corporation)
- Raybiotech, Inc.
- Z Biotech, Llc.
- Chemily Glycoscience
- Dextra Laboratories Ltd.
- Lectenz Bio
The report covers the below scope:
- Global market sizes from 2020 to 2026, along with CAGR for 2020-2026
- Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021, and forecast from 2022 to 2026
- Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the market
- Major market opportunities and challenges in the forecast timeframe to be focused
- Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
- Comprehensive company profiles of the key industry players
The years considered for the study are as follows:
- Base year - 2020
- Estimated year - 2021
- Projected year - 2022
- Forecast period - 2022 to 2026
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers a competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Merck KGaA, Thermo Fisher Scientific, Takara Bio, Inc., New England Biolabs, S-Bio (Subsidiary of Sumitomo Bakelite Co., Ltd.), Aspatria Glycomics S.L., Agilent Technologies, Bio-Techne, Shimadzu Corporation, Bruker Corporation, and others.
Why Buy this Report:
- Gain detailed insights on the Glycomics industry trends
- Find a complete analysis of the market status
- Identify the market opportunities and growth segments
- Analyze competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Target Audience:
The report targeted the existing players in the industry is as follows:
- Market Manufacturers/Service Providers
- Market Wholesale/Traders
- Investment and Financial Institutions
Free and Paid Customization based on the requirement
Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Glycomics Market, By Product
5.1 Introduction
5.2 Enzymes
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Other Enzymes
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Instruments
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Kits
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Carbohydrates
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Reagents & Chemicals
5.7.1 Market Overview
5.7.2 Market Size and Forecast
- Glycomics Market, By Application
6.1 Introduction
6.2 Drug Discovery & Development
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Disease Diagnostics
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Other Applications
6.4.1 Market Overview
6.4.2 Market Size and Forecast
- Glycomics Market, By End User
7.1 Introduction
7.2 Academic Research Institutes
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Pharmaceutical and Biotechnology Companies
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Clinical Laboratories
7.4.1 Market Overview
7.4.2 Market Size and Forecast
- Glycomics Market, By Geography
8.1 Introduction
8.2 Europe
8.2.1 Europe Market, By Product
8.2.2 Europe Market, By Application
8.2.3 Europe Market, By End User
8.3 North America
8.3.1 North America Market, By Product
8.3.2 North America Market, By Application
8.3.3 North America Market, By End User
8.4 Asia Pacific
8.4.1 Asia Pacific Market, By Product
8.4.2 Asia Pacific Market, By Application
8.4.3 Asia Pacific Market, By End User
8.5 Rest of The World
8.5.1 Rest of The World Market, By Product
8.5.2 Rest of The World Market, By Application
8.5.3 Rest of The World Market, By End User
- Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
- Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
- Merck KGaA
- Thermo Fisher Scientific
- Takara Bio, Inc.
- New England Biolabs
- S-Bio (Subsidiary of Sumitomo Bakelite Co., Ltd.)
- Asparia Glycomics S.L.
- Agilent Technologies
- Bio-Techne
- Shimadzu Corporation
- Bruker Corporation
- Waters Corporation
- AB Sciex Pte. Ltd. (Subsidiary of Danaher Corporation)
- Raybiotech, Inc.
- Z Biotech, Llc.
- Chemily Glycoscience
- Dextra Laboratories Ltd.
- Lectenz Bio
The global Glycomics market has been segmented as below:
By Product
- Enzymes
- Other Enzymes
- Instruments
- Kits
- Carbohydrates
- Reagents & Chemicals
By Application
- Drug Discovery & Development
- Disease Diagnostics
- Other Applications
By End-User
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
Glycomics Market, By Company
- Merck KGaA
- Thermo Fisher Scientific
- Takara Bio, Inc.
- New England Biolabs
- S-Bio (Subsidiary of Sumitomo Bakelite Co., Ltd.)
- Asparia Glycomics S.L.
- Agilent Technologies
- Bio-Techne
- Shimadzu Corporation
- Bruker Corporation
- Waters Corporation
- AB Sciex Pte. Ltd. (Subsidiary of Danaher Corporation)
- Raybiotech, Inc.
- Z Biotech, Llc.
- Chemily Glycoscience
- Dextra Laboratories Ltd.
- Lectenz Bio